Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: May 4, 2012
Event: Entry into a new material definitive credit agreement and termination of a prior agreement.
Key Financial Metrics and Liquidity
- New Credit Facility: $1,100,000,000 five-year unsecured revolving credit agreement.
- Purpose: General corporate purposes.
- Administrative Agents: JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association.
- Financial Covenants: The agreement contains only one financial covenant: a consolidated leverage ratio.
- Interest Rate Structure: Borrowings may be based on a Base Rate or LIBOR plus an applicable margin determined by the Company's credit rating.
- Fees: Subject to quarterly facility fees and letter of credit fees, both varying by credit rating.
Material Changes Versus Prior Period
- Termination of Prior Agreement: The Company terminated its existing credit agreement dated April 16, 2008, which was scheduled to mature on April 16, 2013.
- Cost of Termination: No material termination fees or penalties were incurred.
- Lender Relationships: Certain lenders under the new agreement have pre-existing relationships with the Company, including participation in prior credit facilities, share repurchase programs, and bond offerings.
Outlook, Risks, and Contingencies
- Covenants: The agreement includes customary affirmative and negative covenants, including restrictions on liens, consolidations, mergers, and asset sales.
- Events of Default: Includes nonpayment, covenant defaults, breaches of representations, bankruptcy, insolvency, cross defaults, and change of control.
- Management Commentary: The filing does not provide specific management commentary on future performance or strategic outlook beyond the execution of the financing agreement.
Key Facts for Investor Verification
- Verify the specific terms of the consolidated leverage ratio covenant in the attached Credit Agreement (Exhibit 10.1).
- Confirm the current credit rating of The Clorox Company to determine applicable interest rate margins and facility fees.
- Review the full text of Exhibit 10.1 for detailed restrictions on asset sales and mergers.
- Check subsequent filings for any actual borrowings drawn against the new $1.1 billion facility.